Strategic Disinvestment of PSUs: Are we missing the big picture?, The Week, 18 April 2020.

Global Innovation Index: Key Takeaways for India, Observer Research Foundation, 30 August 2019

Is Technology Driving the US-China Trade War?, Global South Colloquy, 19 June 2019

Big Opportunity for India, Down To Earth, 1-15 May 2020.

Reducing India’s Import Dependence of APIs: A possible way out, Express Pharma, 31 March 2020.

Special 301 Report 2019: A Deliberate attempt to weaken India’s Patents Act and to tarnish Indian generic pharmaceutical industry, Express Pharma, 1 May 2019

Mike Pompeo’s Visit and the Tussle Over Data Localization, LiveMint, 20 June 2019.

US tries to thwart TRIPS flexibilities in the midst of a pandemic, LiveMint, 01 May 2020.

Compulsory License Needed in India to ensure affordable medicines, The Wire, 7 May 2016

As Modi Visits US, what does the Free Trade Pact Mean for India’s Pharma Industry?, The Wire, 21 September 2019.

Drug pricing is certainly not the issue in growing dependence on China, Financial Express, 6 August 2020.

Revamping the Indian Start-up Ecosystem, Financial Express, 12 December 2019.

Draft Pharmaceutical Policy 2017: Needs more clarity and clear road maps, ET Healthworld, 31 August 2017

The Ranbaxy Model and Consolidation in Pharma Sector, Economic Times, 24 June 2008.

Investment Facilitation: New Dynamism at WTO on Investment, Columbia FDI Perspective 235, Columbia Centre on Sustainable Investment, 24 September 2018.